Australia markets closed

Cardiovascular Systems, Inc. (CSII)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.06-0.28 (-0.79%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 51.39B
Enterprise value 31.14B
Trailing P/E N/A
Forward P/E 1-876.50
PEG ratio (5-yr expected) 1-0.83
Price/sales (ttm)5.88
Price/book (mrq)5.17
Enterprise value/revenue 34.82
Enterprise value/EBITDA 6-59.01

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 3-30.63%
S&P500 52-week change 312.20%
52-week high 355.22
52-week low 326.00
50-day moving average 332.51
200-day moving average 334.71

Share statistics

Avg vol (3-month) 3334.94k
Avg vol (10-day) 3343.21k
Shares outstanding 539.5M
Float 38.25M
% held by insiders 13.28%
% held by institutions 195.36%
Shares short (30 Aug 2020) 41.35M
Short ratio (30 Aug 2020) 44.14
Short % of float (30 Aug 2020) 44.94%
Short % of shares outstanding (30 Aug 2020) 43.41%
Shares short (prior month 30 Jul 2020) 41.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 325 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2020
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin -11.51%
Operating margin (ttm)-9.54%

Management effectiveness

Return on assets (ttm)-5.05%
Return on equity (ttm)-13.07%

Income statement

Revenue (ttm)236.54M
Revenue per share (ttm)6.90
Quarterly revenue growth (yoy)-37.60%
Gross profit (ttm)187.79M
EBITDA -19.34M
Net income avi to common (ttm)-27.24M
Diluted EPS (ttm)-0.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)232.15M
Total cash per share (mrq)5.85
Total debt (mrq)21.25M
Total debt/equity (mrq)7.90
Current ratio (mrq)6.46
Book value per share (mrq)6.78

Cash flow statement

Operating cash flow (ttm)-12.77M
Levered free cash flow (ttm)1.99M